23andMe Holding Company (ME) Actualités

23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology

SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading...

Form 4 - Statement of changes in beneficial ownership of securities

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation

SUNNYVALE, Calif. and SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a...

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

23andMe Reports Second Quarter Fiscal Year 2025 Financial Results

SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human...

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future

Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues...

CORRECTION - 23andMe to Report Q2 FY2025 Financial Results

SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- An earlier release under the same headline should have...

23andMe to Report Q2 FY2025 Financial Results

SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading...

Form 8-K - Current report

23andMe Regains Compliance With Nasdaq Listing Requirements

SUNNYVALE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or...

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 8-K - Current report